Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Boehringer Ingelheim
Scientific Title
An Open Label, Randomized Phase II Study of BI 754091 Alone or in Combination With BI 836880 in Patients With Chemotherapy Resistant, Unresectable, Metastatic Squamous Cell Carcinoma of the Anal Canal